Simulating mild systematic and focal demyelinating neuropaties: Membrane property abnormalities

Journal of Integrative Neuroscience

Volumn 5, Issue 4, 2006, Pages 595-633

  Stephanova, D I ^a   Alexandrov, A S ^a  

^a INSTITUTE OF BIOPHYSICS AND BIOMEDICAL ENGINEERING   (Bulgaria)

Author keywords

Charcot Marie Tooth disease type 1A; Chronic inflammatory demyelinating polyneuropathy; Computational neuroscience; Excitability properties; Guillain Barr syndrome; Potentials

Indexed keywords

ARTICLE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; DEMYELINATING NEUROPATHY; DEMYELINATION; GUILLAIN BARRE SYNDROME; HEREDITARY MOTOR SENSORY NEUROPATHY; MOTOR NERVE; MYELIN SHEATH; NERVE EXCITABILITY; NERVE MEMBRANE; SIMULATION;

ACTION POTENTIALS; COMPUTER SIMULATION; ELECTRIC STIMULATION; HUMANS; MEMBRANE POTENTIALS; MODELS, NEUROLOGICAL; NERVE FIBERS, MYELINATED; NEURAL CONDUCTION; POLYRADICULONEUROPATHY; REACTION TIME;

EID: 33846530656     PISSN: 02196352     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0219635206001331     Document Type: Article

References (47)

1. Awiszus F, Effect of paranodal potassium permeability on repetitive activity of mammalian myelinated nerve fiber models, Biol Cybern 64:69-76, 1990.
2. Barohn RJ, Kissel JT, Warmolts JR, Mendell JR, Chronic inflammatory demyelinating polyradiculoneuropathy; clinical characteristics, course and recommendations for diagnostic criteria, Arch Neurol 46:878-884, 1989.
3. Berthold C, Morphology of normal peripheral axons, in Waxman S (ed.), Physiology and Pathology of Axons, Raven Press, New York, pp. 3-63, 1978.
4. Blight A, Computer simulation of action potentials and afterpotentials in mammalian myelinated axons: The case for a low resistance myelin sheath, Neuroscience 15:13-31, 1985.
5. Birouk N, Gouider R, Le Guern E, Gugenheim M, Tardieu S, Maisonobe T, Le Forestier N, Agid Y, Brice A, Bouche P, Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases, Brain 120:813-823, 1997.
6. Bostock H, Baker M, Reid G, Changes in excitability of human motor axons underlying post-ischaemic fasciculations: Evidence for two stable states, J Physiol 441:537-557, 1991.
7. Bostock H, Burke D, Hales JP, Differences in behavior of sensory and motor axons following release of ischemia, Brain 117:225-234, 1994.
8. Bostock H, Cikurel K, Burke D, Threshold tracking techniques in the study the human peripheral nerve, Muscle Nerve 21:137-158, 1998.
9. Bostock H, Rothwell JC, Latent addition in motor and sensory fibers of human peripheral nerve, J Physiol (Lond) 498:277-294, 1997.
10. Cappelen-Smith C, Kuwabara S, Lin CS, Mogyoros I, Burke D, Membrane properties in chronic inflammatory demyelinating polyneuropathy, Brain 124:2439-2447, 2001.
11. Chang AP, England JD, Garcia CA, Summer AJ, Focal conduction block in n-hexane polyneuropathy, Muscle Nerve 21:964-969, 1998.
12. Choudhury D, Arora D, Axonal Guillain-Barré syndrome: A critical review, Acta Neurol Scan 103:267-277, 2001.
13. Daskalova M, Stephanova DI, Strength-duration properties of human myelinated motor and sensory axons in normal case and in amyotrophic lateral sclerosis, Acta Physiol Pharmacol Bulg 26:11-14, 2001.
14. Dimitrov AG, Internodal sodium channels ensure active processes under myelin manifesting in depolarizing afterpotentials, J Theor Bibl 235:451-462, 2005.
15. Dioszeghy P, Stålberg E, Changes in motor and sensory nerve conduction parameters with temperature in normal and diseased nerve, Electroencephalogr Clin Neurophysiol 85:229-235, 1992.
16. Dyck PJ, Chance P, Lebo R, Camey AJ, Hereditary motor and sensory neuropathies, in Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF (eds.), Peripheral Neuropathy, 3rd ed., W.B. Saunders, Philadelphia, pp. 1094-1136, 1993.
17. Feasby TE, Gilbert JJ, Brown WF, Bolton CF, Hahn AF, Koopman WF, Zochodne DW, An acute axonal form of Guillain-Barré polyneuropathy, Brain 109:1115-1126, 1986.
18. Gorson KC, Ropper AH, Adelman LS, Weinberg DH, Influence of diabetes mellitus on chronic inflammatory demyelinating polyneuropathy, Muscle Nerve 23:37-48, 2000.
19. Greene DA, Yagihashi S, Lattimer SA, Sima AAF, Nerve NaC/KC-ATPase, conduction, and myo-inositol in the insulin deficient BB rat, Am J Physiol 247:E534-E539, 1984.
20. Greene DA, Lattimer SA, Sima AAF, Are disturbance of sorbitol, phosphoinositide, and NaC/KC-ATPase regulation involved in pathogenesis of diabetic neuropathy?, Diabetes 37:688-693, 1988.
21. Griffin JW, Li CY, Ho TW, Xue P, Macko C, Gao CY, Yang C, Tian M, Mishu B, Cornblath DR, Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases, Brain 118:575-595, 1995.
22. Halter J, Clark J, A distributed-parameter model of the myelinated nerve fiber, J Theor Biol 148:345-382, 1991.
23. Kaji R, Physiology of conduction block in multifocal motor neuropathy and other demyelinating neuropathies, Muscle Nerve 27:285-296, 2003.
24. Katz JS, Saperstain DS, Gronseth G, Amato AA, Barohn RJ, Distal acquired demyelinating symmetric neuropathy, Neurology 54:615-620, 2000.
25. Kiernan MC, Burke D, Andersen KV, Bostock H, Multiple measures of axonal excitability: A new approach in clinical testing, Muscle Nerve 23:399-409, 2000.
26. Kuwabara S, Nakajima M, Tsuboi Y, Hirayama K, Multifocal conduction block in n-hexane neuropathy, Muscle Nerve 16:1416-1417, 1993.
27. Kuwabara S, Ogawara K, Sung JY, Mori M, Kanai K, Hattori T, Yuki N, Lin CS, Burke D, Bostock H, Differences in membrane properties of axonal and demyelinating Guillain-Barré syndromes, Ann Neurol 52:180-187, 2002.
28. Kuwabara S, Bostock H, Ogawara K, Sung JY, Kanai K, Mori M, Hattori T, Burke D, The refractory period of transmission is impaired in axonal Guillain-Barré syndrome, Muscle Nerve 28:683-689, 2003.
29. Low PA, Recent advances in the pathogenesis of diabetic neuropathy, Muscle Nerve 10:121-128, 1987.
30. Mareska M, Gutmann L, Lambert-Eaton myasthenic syndrome, Semin Neurol 24(2): 149-153, 2004.
31. Newson-Davis J, Lambert-Eaton myasthenic syndrome, Rev Neurol (Paris) 160(2): 177-180, 2004.
32. Nodera H, Bostock H, Kuwabara S, Sakamoto T, Asanuma K, Sung JY, Ogawara K, Hattori N, Hirayama M, Sobue G, Kaji R, Nerve excitability properties in Charcot-Marie-Tooth disease type A1, Brain 127:203-211, 2004.
33. Paul T, Katiyar BC, Misra S, Pant CC, Carcinomatous neuromuscular syndromes, A clinical and quantitative electrophysiological study, Brain 101:53-63, 1978.
34. Priori A, Bossi B, Ardolino G, Bertolasi L, Carpo M, Nobile-Orazio E, Baxbieri S, Pathophysiological heterogeneity of conduction blocks in multifocal motor neuropathy, Brain 128:1642-1648, 2005.
35. Stephanova DI, Bostock H, A distributed-parameter model of the myelinated human motor nerve fiber: Temporal and spatial distributions of action potentials and ionic currents, Biol Cybern 73:275-280, 1995.
36. Stephanova DI, Bostock H, A distributed-parameter model of the myelinated human motor nerve fiber: Temporal and spatial distributions of electrotonic potentials and ionic currents, Biol Cybern 74:543-547, 1996.
37. Stephanova DI, Chobanova M, Action potentials and ionic currents through paranodally demyelinated human motor nerve fibers: Computer simulations, Biol Cybern 76:311-314, 1997.
38. Stephanova DI, Daskalova M, Differences in potentials and excitability properties in simulated cases of demyelinating neuropathies. Part II. Paranodal demyelination, Clin Neurophysiol 116:1159-1166, 2005.
39. Stephanova DI, Daskalova M, Differences in potentials and excitability properties in simulated cases of demyelinating neuropathies. Part III. Paranodal internodal demyelination, Clin Neurophysiol 116:2334-2341, 2005.
40. Stephanova DI, Daskalova M, Alexandrov AS, Differences in potentials and excitability properties in simulated cases of demyelinating neuropathies. Part I, Clin Neurophysiol 116:1153-1158, 2005.
41. Stephanova DI, Daskalova M, Alexandrov AS, Differences in membrane properties in simulated cases of demyelinating neuropathies. Internodal focal demyelinations without conduction block, J Biol Phys 32:61-71, 2006.
42. Stephanova DI, Daskalova M, Alexandrov AS, Differences in membrane properties in simulated cases of demyelinating neuropathies. Internodal focal demyelinations with conduction block, J Biol Phys 32:129-144, 2006.
43. Stephanova D, Kossev A, Action potentials and ionic currents through internodally demyelinated human motor nerve fibers: I. Computer simulations, Comp Rend l'Acad Bulg Sci 50(1):107-110, 1997.
44. Stephanova DI, Mileva K, Different effects of blocked potassium channels on action potentials, accommodations, adaptation and anode break excitation in human motor and sensory myelinated nerve fibers: Computer simulations, Biol Cybern 83:161-167, 2000.
45. Stephanova D, Trayanova N, Gydikov A, Kossev A, Extracellular potentials of a single myelinated nerve fiber in an unbounded volume conductor, Biol Cybern 61:205-210, 1989.
46. Sung JY, Kuwabara S, Kaji R, Ogawara K, Mori M, Kanai K, Nodera H, Hattori T, Bostock H, Threshold electrotonus in chronic inflammatory demyelinating polyneuropathy: Correlation with clinical profiles, Muscle Nerve 29:28-37, 2004.
47. Zambelis T, Foutsitzi A, Giannokopoulou A, Poulopoulou K, Karndreareas N, Lambert-Eaton myasthenic syndrome. Clinical and Electrophysiological findings in seven cases, Electromyogr Clin Neurophysiol 44:289-292, 2004.